Microbiome Skincare: Companies, Startups & Research

Beiersdorf AG, BASF and DSM-Firmenich are among the companies named in microbiome skincare activity. Beiersdorf launched Eucerin DERMOPURE CLINICAL PROBIOM8, based on viable skin-native probiotics. BASF holds patents on microbiome-friendly substances and cosmetic formulations, while DSM-Firmenich has researched skin and scalp postbiotics and developed 3D facial microbiome mapping.

Kins, Seed Health Inc. and Postbiotica S.R.L. are startups with named work in this field. Kins studies a fermented soy-milk postbiotic and its potential effects on beneficial skin commensals. Seed Health describes formulations using bacterial strains, derivatives and prebiotics. Postbiotica’s research examines a Lacticaseibacillus paracasei-derived postbiotic for age-related skin damage; these examples indicate different product and research directions, not a ranking.

Stanford University, the University of Queensland and Universidade Federal De Sao Paulo are among the research organizations with named work. Stanford explores engineering skin microbiota for topical applications, including resident microbes as delivery platforms. The University of Queensland has used metagenomic profiling to inform skincare research, while Universidade Federal De Sao Paulo has reviewed microbiome-friendly formulations and cosmetic development.

The funding indicators list 41 grants since 2020 totaling $36.8 million and 28 funding rounds totaling $5.32 billion. These are aggregate records associated with the topic and may include items not directly tied to microbiome skincare research or products. Check individual records before using the totals to assess funding available for a specific technology or organization.

AOBiome leads the listed patent holders with 19 patents. Conopco is listed with 6, while Colgate Palmolive, The Regents Of The University Of California and Igen Biolab each have 4. The list also includes Natura Cosmeticos S.A. and Seed Health Inc. with 3 each, and BASF with 2.

Patent activity fell 53.5% in the defined comparison window, even as publications rose 38.8% in the latest year. The figures suggest research output is currently growing more strongly than patenting. They do not show whether individual product categories or companies are increasing their patent activity, so scouts should compare specific approaches and patent holders.

Recent developments include Beiersdorf’s September 2026 launch of Eucerin DERMOPURE CLINICAL PROBIOM8 and DSM-Firmenich’s 3D facial microbiome mapping, reported in June 2026. Research in September 2026 described an ex vivo model for preserving donor-specific microbiota and studied a postbiotic derived from Lacticaseibacillus paracasei CNCM I-5220 for age-related skin damage.

The five approaches are live microbial formulations, prebiotic formulations, postbiotics and ferments, microbiome-selective modulators, and microbiome profiling and personalization. Live products deliver microbes but face viability challenges. Prebiotics supply substrates, while postbiotics use microbial products or inactivated material. Modulators aim to influence microbial activity selectively; profiling uses microbiota data to inform product decisions.

Sensitive and atopic skin is the largest listed application, with 1,706 documents and 49 patents in the window. Other applications include anti-aging and photoaging, skin barrier and hydration, acne and blemish care, and scalp care. Recent research also examines oily skin, age-related skin damage and microbiome-targeting products used alongside acne treatment.

The United States leads the listed geography with 9,408 documents, followed by the United Kingdom with 3,299 and Germany with 2,582. France, Japan and India are also among the countries with substantial activity. These document counts indicate where activity is recorded, but do not by themselves measure product readiness or the strength of local research.